SCHEMBL4190912

SCHEMBL4190912

C=CC(=O)OC(COc1ccc(C)cc1OCC(COc1ccccc1-c1ccccc1)OC(=O)C=C)COc1ccccc1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.47
LMNA P02545 6/20 0.46
L3MBTL1 Q9Y468 5/20 0.46
TDP1 Q9NUW8 3/20 0.46
MAPK1 P28482 3/20 0.46
HTT P42858 6/20 0.42
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
GLA P06280 1/20 0.41
RAB9A P51151 1/20 0.41
PAX8 Q06710 1/20 0.41
MAPT P10636 3/20 0.40
HSP90AA1 P07900 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ADRB2 P07550 2/20 0.39
ADRB1 P08588 1/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 4/20 0.39
USP2 O75604 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4194281 0.90 HTT (0.47) LMNAL3MBTL1TDP1MAPK1HTT
SCHEMBL4191519 0.87 HTT (0.47) LMNAL3MBTL1TDP1MAPK1HTT
SCHEMBL4195597 0.85 L3MBTL1 (0.43) LMNAL3MBTL1TDP1MAPK1HTT
SCHEMBL4202047 0.84 HTT (0.44) LMNAL3MBTL1TDP1MAPK1HTT
SCHEMBL18492223 0.84 HTT (0.46) LMNAL3MBTL1TDP1MAPK1HTT
SCHEMBL25124049 0.83 KDM4E (0.42) LMNAL3MBTL1TDP1MAPK1HTT
SCHEMBL4197888 0.83 L3MBTL1 (0.44) LMNAL3MBTL1TDP1MAPK1HTT
SCHEMBL4193448 0.83 HTT (0.44) LMNAL3MBTL1TDP1MAPK1HTT
SCHEMBL4188679 0.82 HTT (0.43) LMNAL3MBTL1TDP1MAPK1HTT
SCHEMBL4190443 0.82 HTT (0.43) LMNAL3MBTL1TDP1MAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627867-B1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF MITSUI CHEMICALS INC (JP) 2016-01-20 EP disclosed
US-7534909-B2 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2009-05-19 US disclosed
US-20070078198-A1 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2007-04-05 US disclosed
EP-1627867-A1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078198-A1 (Meth) acrylic ester compound and use thereof METTL14, PAM, TAS2R41 PTGDR2 468/4885LMNA 4549/4885L3MBTL1 2124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.